Company Details
Overview
Developing glycan-targeted therapies for respiratory infections and cancer.
Total Raised
$23 M
Rounds
4
Links
Verticals
Biotechnology
Health Care
Wellness
Investment History
Equity
Jun 2023
$10M
Equity
Jan 2022
$5M
Equity
Jan 2021
$3M
Equity
May 2020
$5M